{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8WVF1",
      "entity_text" : "NOR-1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03230",
      "entity_text" : "agomiR-106b-5p",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Activated NOR-1 increased cell invasion in the agomiR-106b-5p treatment group, the invasive cell count was 40.7 +/-3.84 and 53.7 +/-2.60 in the agomiR-106b-5p group and the NOR-1 + agomiR-106b-5p group, respectively (XREF_FIG).",
  "reading_complete" : "2020-08-03T15:48:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:47:52Z",
  "trigger" : "Activated",
  "evidence" : [ "Activated NOR-1 increased cell invasion in the agomiR-106b-5p treatment group, the invasive cell count was 40.7+/-3.84 and 53.7+/-2.60 in the agomiR-106b-5p group and the NOR-1 + agomiR-106b-5p" ],
  "pmc_id" : "7138273",
  "score" : 0
}